DTIs offer several advantages over traditional anticoagulants like warfarin and heparin. They have a more predictable pharmacokinetic profile, require less frequent monitoring, and have fewer dietary and drug interactions. However, the cost of DTIs can be higher, and their use may be limited in certain populations due to the risk of bleeding complications.
